Scribe Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 02/09/2026 | Mar 2026Filed 02/09/2026 | Jun 2025Filed 02/09/2026 | Mar 2025Filed 02/09/2026 |
|---|---|---|---|---|
| $1.9 | — | $4.9 | — | |
| −$6.5 | −$17 | −$9.9 | −$3.4 | |
| −$2.62 | — | −$4.08 | — | |
| 2.5 | — | 2.4 | — |
Trend